COMP <GO>
BAM vs CVSA // EV/EBITDA & P/E VALUATION
Brookfield Asset Management Inc Class A Limited Voting Shares (NYSE) VS. Covista Inc. (NYSE) • 15-METRIC TALLY: BAM 9
— CVSA 4
▲ EV/EBITDA & P/E VALUATION LEADER: CVSA
LAST: $48.26 (-0.70%) • MKT CAP: $77.63B
valuation
25.6x
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
valuation
12.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BAM VS. CVSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BAM | CVSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 56.90% | -15.90 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.00% | 14.80% | +5.20 | BAM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 25.6x | 12.5x | +13.10 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 2.48% | 6.60% | -4.12 | CVSA | /fcf-yield <GO> |
| Operating Margin | 74.20% | 19.10% | +55.10 | BAM | /operating-margins <GO> |
| Net Profit Margin | 60.80% | 13.30% | +47.50 | BAM | /net-margins <GO> |
| Revenue Growth (YoY) | 16.70% | 12.90% | +3.80 | BAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.63% | 3.40% | +0.23 | BAM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.93 | 4.73 | +3.20 | BAM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.10% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 43.0 | +18.10 | BAM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.05 | +0.01 | BAM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.2x | 15.5x | +11.70 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $77.63B | $4.36B | $73.27B | BAM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BAM REV | CVSA REV | BAM GROSS % | CVSA GROSS % | BAM FCF | CVSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.94B | $1.79B | 44.0% | 56.9% | $1.92B | $287.6M |
| FY 2024 | $3.38B | $1.58B | 44.0% | 55.9% | $1.46B | $246.9M |
| FY 2023 | $3.14B | $1.45B | 44.0% | 44.0% | $1.30B | $126.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BAM // BETA 1.06
CVSA // BETA 1.05